Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Sotagliflozin by Lexicon Pharmaceuticals for Hypertrophic Cardiomyopathy: Likelihood of Approval
Sotagliflozin is under clinical development by Lexicon Pharmaceuticals and currently in Phase III for Hypertrophic Cardiomyopathy. According to GlobalData, Phase...
Data Insights
Sotagliflozin by Lexicon Pharmaceuticals for Type 1 Diabetes (Juvenile Diabetes): Likelihood of Approval
Sotagliflozin is under clinical development by Lexicon Pharmaceuticals and currently in Pre-Registration for Type 1 Diabetes (Juvenile Diabetes). According to...